201 related articles for article (PubMed ID: 25268356)
1. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
[TBL] [Abstract][Full Text] [Related]
2. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
Xia Y; Guo XG; Ji TX
Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
Shen W; Cao X; Xi L; Deng L
Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
[TBL] [Abstract][Full Text] [Related]
4. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
Meng D; Wu YX; Heerah V; Peng S; Chu MD; Xu YJ; Xiong WN; Xu SY
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):319-326. PubMed ID: 26072067
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
[TBL] [Abstract][Full Text] [Related]
7. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
8. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
9. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population.
Liu W; Zhu E; Wang R; Wang L; Liu T
Med Oncol; 2012 Jun; 29(2):677-81. PubMed ID: 21298365
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1 G801A polymorphism and the risk factors for cervical cancer.
Roszak A; Misztal M; Sowińska A; Jagodziński PP
Mol Med Rep; 2015 Jun; 11(6):4633-8. PubMed ID: 25672413
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan.
Shi MD; Chen JH; Sung HT; Lee JS; Tsai LY; Lin HH
Arch Med Sci; 2013 Dec; 9(6):999-1005. PubMed ID: 24482642
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 G801A polymorphism is associated with significant liver fibrosis in HIV-infected Thais: a cross-sectional study.
Chiraunyanann T; Changsri K; Sretapunya W; Yuenyongchaiwat K; Akekawatchai C
Asian Pac J Allergy Immunol; 2019 Sep; 37(3):162-170. PubMed ID: 30447648
[TBL] [Abstract][Full Text] [Related]
15. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
[TBL] [Abstract][Full Text] [Related]
16. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
[TBL] [Abstract][Full Text] [Related]
17. Association of single nucleotide polymorphism rs3803662 with the risk of breast cancer.
Yang Y; Wang W; Liu G; Yu Y; Liao M
Sci Rep; 2016 Jun; 6():29008. PubMed ID: 27350156
[TBL] [Abstract][Full Text] [Related]
18. Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects.
Sun H; Bai J; Chen F; Jin Y; Yu Y; Fu S
Breast Cancer Res Treat; 2011 Jan; 125(1):175-9. PubMed ID: 20464476
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism-801G/A in the 3'-untranslated region of CXCL12 is not associated with preeclampsia in Chinese Han population.
Xu J; Chen K; Li A; Guo M; Wang J; Liu S; Wang X
Clin Exp Hypertens; 2017; 39(1):23-28. PubMed ID: 28051881
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibility: a meta-analysis.
Xie F; Sun Q; Wu S; Xie X; Liu Z
Genet Test Mol Biomarkers; 2014 Aug; 18(8):591-5. PubMed ID: 25051148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
